Espansione Group

Yesterday evening, we came together at our manufacturing site in Crevalcore for a wonderful Christmas dinner with all our amazing colleagues.🎄🎄🎄 It was a heartfelt moment of connection and celebration as we reflected on the milestones we’ve achieved together this year. A warm thank you to everyone who made the evening unforgettable and to the Comunità San Patrignano for their thoughtful contribution, making the evening even more special. As the year comes to a close, we want to express our heartfelt gratitude to our Distributors, KOLs, Doctors, and collaborators worldwide.💕 Your support and trust have been the cornerstone of our success this year. Wishing you all a Merry Christmas, a Happy New Year, and an inspiring start to 2025. We can’t wait to see what the future holds for us! 🥂✨ #espansionegroup #scienceonward #lightmodulation #lllt

For heaps of practical tips bout how to build a dry eye practice, join us in the midst of the Quantock Hills as we spend an evening at home with Sarah Farrant, the President of the British Contact Lens Association. With her trademark infectious enthusiasm, Sarah talks about her holistic and evidence based approach to managing the dry eye disease patient, the multifaceted aetiology of this condition and why our modern lifestyles are causing its prevalence to rise inexorably. Sarah shares her top tips about dry eye practice, how to use IPL and LLLT to best effect, and the importance of setting realistic goals for our patients at the outset of treatment. We hope you enjoy this festive listen https://pod.fo/e/2931cb Or visit https://lnkd.in/eXAr3JnD #dryeyedisease #ophthalmology #optometry #IPL #LLLT #Thea #Orbis #BCLA #TheNewOptometrist #SarahFarrant #DermotKeogh #Topcon #EyeNews

Join Prof Enrico Borrelli in our In-Sight Webinar Series to discover Light Modulation™ LLLT (PBM), a novel, non-invasive technology for dry Age-Related Macular Degeneration (dAMD) management. As the lead investigator of the LightWave I clinical trial, Prof. Enrico Borrelli will present groundbreaking results from this longitudinal, double-masked, multicentric study. The findings confirm the safety, tolerability, and short-term efficacy of LM™ LLLT (PBM), showcasing improved visual acuity and reduced drusen volume in patients with dAMD. This keynote, first presented at Euretina 2024, highlights the clinical potential of LM™ LLLT  in managing this retinal condition. ✨ Stay up-to-date and be the first to get a sneak peek into the innovations coming in the 2025 webinar series! 📅 Save your spot for Wednesday, 18 Dec 2024 - 04:30 PM (CET)  Register now to stay ahead! 👉 https://lnkd.in/dwgXvq3z 💡 Can’t make it? No problem! Register today, and we’ll send you the replay link after the event. #espansioegroup #sceinceonward #lightmodulation #PBM #LightWaveI #dAMD #retina #drusenreduction #posteriorsegment #dryAMD

We are continuing to expand in the med-tech space with today’s announcement of an agreement to acquire Espansione Group, an Italy-based company specializing in the design and manufacturing of non-invasive medical devices, protected by international patents, for the diagnosis and treatment of dry-eye, ocular surface, and retinal diseases  This investment proudly made in one of our home countries, will expand our portfolio of medical devices and solidify our role in the optical industry.    Read more: https://lnkd.in/d78ctJXX #WeAreEssilorLuxottica 

Join Prof. Enrico Borrelli in our In-Sight Webinar Series to discover Light Modulation™ LLLT (PBM), a novel, non-invasive technology for dry Age-Related Macular Degeneration (dAMD) management. As the lead investigator of the LightWave I clinical trial, Prof. Enrico Borrelli will present groundbreaking results from this longitudinal, double-masked, multicentric study. The findings confirm the safety, tolerability, and short-term efficacy of  LM™ LLLT (PBM), showcasing improved visual acuity and reduced drusen volume in patients with dAMD. This keynote, first presented at Euretina 2024, highlights the clinical potential of  LM™ LLLT  in managing this retinal condition. ✨ Stay up-to-date and be the first to get a sneak peek into the innovations coming in the 2025 webinar series! 📅 Save your spot for Wednesday, 18 Dec 2024 - 04:30 PM (CET)  Register now to stay ahead!👇 https://lnkd.in/dwgXvq3z 💡 Can’t make it? No problem! Register today, and we’ll send you the replay link after the event. #espansionegroup #sceinceonward #lightmodulation #PBM #LightWaveI #dAMD #retina #drusenreduction #posteriorsegment #dryAMD

💥 What an incredible journey at FLORetina 2024—it's a wrap! 💥 We witnessed an immense interest in our innovative LM™ LLLT (PBM) technology, presenting a promising approach for managing dAMD, and its potential role in the management of other challenging retinal conditions. 🔥 Our Lunch Symposium drew a packed audience, sparking engaging discussions and reaffirming the growing excitement for this groundbreaking technology. 🚀 Thank you to everyone who joined us and shared their insights—it’s inspiring to see such dedication to advancing retinal care. Together, we’re shaping the future of ophthalmology!  Giuseppe Giannaccare Enrico Borrelli Sibel Demirel Daniela Bacherini #espansionegroup #sceinceonward #PBM #dAMD #cCSC #lightmodulation #lllt #LightWaveI #drusenreduction

Join Dr. Sarah Farrant and Dr Sònia Travé-Huarte in our In-Sight Webinar Series as they present their groundbreaking research and clinical experience with Blue Light Modulation™ LLLT (PBM) technology. Originally introduced during their keynote at ESCRS 2024, this session will explore the crucial role of the ocular microbiome in maintaining surface health, the impact of Demodex and saponification on dry eye disease (DED), and how Blue LM™ LLLT provides effective treatment for these conditions. They will also share insights from a pivotal clinical trial investigating LM™ LLLT's role in stabilizing the ocular microbiome. 🌟 Be the First to Discover What's Next! Get an exclusive preview of the exciting innovations in our 2025 webinar series. 📅 Save your spot for Tuesday, December 10th, 2024, at 12:30 PM (CET). Register now to stay ahead!👇 https://lnkd.in/dhK7TMVU... 💡 Can’t make it? No problem! Register today, and we’ll send you the replay link after the event. #espansionegroup #sceinceonward #lightmodulation #microbiome #saponification #demodex #bluelighttherapy #lllt #ocularmicrobiome #bacteriaelimination

What a blast this third day of FLORetina 2024! 🤩 Our Photobiomodulation (PBM) technology LM™ LLLT stole the show, from presentations and abstracts in the programme to our lunch symposium in full house! 🔥 It's truly humbling to witness the support and feedback from the scientific community and the FLORetina association (Prof. Stanislao Rizzo, Prof. Daniela Bacherini)—we'd like to thank you all, both old and new friends, for a great conversation. Looking forward to see what the future holds for non-invasive retinal care, from dAMD and beyond! Prof. Enrico Borrelli, Prof. Giuseppe Giannaccare, Prof., Sibel Demirel, Dr. Claudio Iovino, Dr. Pasquale Viggiano #scienceonward #lllt #pbm #damd #retina

Heading to FLORetina 2024? Be sure to join us for an inspiring session on the latest breakthroughs in retinal care with LM™ LLLT (PBM) technology. 🎤 Lunch Symposium Details: 📅 Saturday, December 7th 🕑 13:45 – 14:30 📍 Orsanmichele Room Led by an esteemed international panel – Prof. Giuseppe Giannaccare, Prof. Enrico Borrelli, Prof. Sibel Demirel, and moderated by Dr. Daniela Bacherini – we’ll explore: > The effectiveness of LM™ LLLT (PBM) in managing Dry Age-related Macular Degeneration (dAMD). > Its potential applications for chronic Central Serous Chorioretinopathy. > Cutting-edge treatments for anterior segment conditions, addressing both the front and back of the eye. Don’t miss this chance to connect, learn, and explore the future of retinal health! #espansionegroup #scienceonward #PBM #retina #eyelight #LightWaveI #dAMD #lightmodulation #drusenreduction #floretina2024

Join Dr. Sarah Farrant and Dr Sònia Travé-Huarte in our In-sight Webinar as they share their expertise and research on Blue Light Modulation™ LLLT (PBM) technology for Demodex, Saponification, and Microbiome Stabilization. 🌟 Dive into the latest insights on: 🔬 The impact of the ocular microbiome on surface health 🔎 The role of Demodex in dry eye disease (DED) 📋 Clinical cases showcasing Blue LM™ LLLT in action 📊 Results from a groundbreaking clinical trial on microbiome stabilization ✨ Stay up-to-date and be the first to get a sneak peek into the innovations coming in the 2025 webinar series! 📩 Sign up now to secure your place!👇 https://lnkd.in/d7_AbMmM #espansionegroup #sceinceonward #lightmodulation #microbiome #saponification #demodex #bluelighttherapy #lllt #ocularmicrobiome #tearfilmstabilization #inflammationreduction #bacteriaelimination